NCT00493818 Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693 Status TERMINATED Phase PHASE1
NCT00492544 Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age Status COMPLETED Phase PHASE3
NCT00492414 Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release Status UNKNOWN Phase PHASE4
NCT00490620 Study of Combivir for Patients With Primary Biliary Cirrhosis Status COMPLETED Phase PHASE2/PHASE3
NCT00490568 Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers Status TERMINATED Phase PHASE3
NCT00490490 Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy Status TERMINATED Phase PHASE2
NCT00490204 Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis Status COMPLETED Phase PHASE3
NCT00490061 Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy Status TERMINATED Phase PHASE2
NCT00489970 Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 Status COMPLETED Phase PHASE3
NCT00489567 Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden Status COMPLETED Phase N/A
NCT00489554 Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age Status COMPLETED Phase PHASE3
NCT00488514 Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents Status COMPLETED Phase PHASE3
NCT00488449 Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00487578 Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction Status TERMINATED Phase PHASE4
NCT00486954 Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT00486668 A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer Status UNKNOWN Phase PHASE3